Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
23/12/2022 11:55 pm
Trying to separate three different claims about BPC-157: that it is the right molecule, that it is the right dose, and that it does something useful.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took six weeks to be sure.
What would change your mind about this?